Naba Alsaha Medical Services Co. reported a 58% decline in net profit to SAR 22 million for 2024, down from SAR 52 million in 2023, following the release of its annual financial results for the period ending December 31, 2024.
The company’s operational profit stood at SAR 25 million at the end of 2024, compared to SAR 43 million in 2023, marking a decrease of 43%.
Total shareholders’ equity, after deducting minority interest, increased by 11% to SAR 200 million, up from SAR 180 million in 2023.
Earnings per share for the year were SAR 2.07, compared to SAR 4.99 in 2023.
According to a statement on Tadawul, the company’s revenue for 2024 increased by SAR 11.9 million, reflecting a 6.54% growth over the previous year. This growth was attributed to a higher number of patients and improved service quality in the hospital sector, which positively impacted sales in the pharmacy sector compared to the previous year.
